Novel approaches to the diagnosis of basal cell nevous syndrome

Expert Review of Molecular Diagnostics

Volumn 2, Issue 4, 2002, Pages 321-328

  High, Alec S ^a   Robinson, Philip A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Basal cell carcinoma; BCNS; Cancer; DNA array; Odontogenic keratocyst; Patched; Proteomics; SNPs

Indexed keywords

ALKALOID; CYCLOPAMINE; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

BASAL CELL NEVUS SYNDROME; CLINICAL FEATURE; GENE MAPPING; GENE SEQUENCE; HETEROZYGOSITY LOSS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; BASAL CELL CARCINOMA; FORECASTING; GENETICS; HUMAN; SKIN TUMOR;

BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; FORECASTING; HUMANS; PHENOTYPE; SKIN NEOPLASMS;

EID: 0036020074     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.2.4.321     Document Type: Review

References (53)

1. Multiple nevoid basal cell epithelioma, jaw cysts and bifid rib syndrome
2. Sun exposure and basal cell carcinomas in the nevoid basal cell carcinoma syndrome
3. Multiple basal cell carcinoma, odontogenic keratocysts and skeletal anomalies syndrome
4. The multiple basal-cell nevi syndrome. An analysis of a syndrome consisting of multiple nevoid-basal cell carcinoma, jaw cysts, skeletal anomalies, medulloblastoma and hyporesponsiveness to parathormone
5. The multiple nevoid basal cell carcinoma syndrome revisited
6. Multiple nevoid basal cell carcinoma syndrome
7. Nevoid basal-cell carcinoma syndrome
8. Nevoid basal cell carcinoma syndrome
9. Multiple cutaneous cancers in children: The nevoid basal cell carcinoma syndrome
10. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma
11. The odontogenic keratocyst. A clinicopathologic study of 312 cases: I. Clinical features
12. High frequency of chromosome 9 deletion in ovarian cancer: Evidence for three tumor-suppressor loci
13. Odontogenic cysts
14. Studies on odontogenic cyst epithelium
15. Recurrence of keratocysts. A long-term follow-up study
16. The emerging epidemic of skin cancer
17. Biology of basal cell carcinoma (Part 1)
18. Basal cell carcinoma
19. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome
20. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9
21. Investigation of chromosome 9q22.3-q 31 DNA marker loss in odontogenic keratocysts
22. Basal cell carcinomas, coarse sparse hair, and milia
23. The Rombo syndrome: A familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis
24. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease
25. Nonsyndromic type of hereditary multiple basal cell carcinoma
26. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia Type 1
27. Location of gene for Gorlin syndrome
28. Mutations of the human homologue of Drosophilia patched in the nevoid basal cell carcinoma syndrome
29. Human homologue of patched, a candidate gene for the basal cell nevus syndrome
30. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system
31. Mutations of the patched gene in several types of 'sporadic' extracutaneous tumors
32. De novo mutations of the patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype
33. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas
34. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: Different in vivo mechanisms of PTCH inactivation
35. Basal cell carcinomas in mice over-expressing sonic hedgehog
36. Dual roles for patched in sequestering and transducing hedgehog
37. Altered neural cell fates & medulloblastoma in mouse patched mutants
38. PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas
39. A frequent activated smoothened mutation in 'sporadic' basal cell carcinomas
40. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
41. Theories of pathogenesis: Mutation and cancer
42. Nevoid basal cell carcinoma syndrome
43. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the patched protein, and no genotype-phenotype correlations are evident
44. Maneuvering in the complex path from genotype to phenotype
45. Expression of the Sonic Hedgehog Receptor patched in basal cell carcinomas and odontogenic keratocysts
46. Gleevec treatment of chronic myelogenous leukemia (CML)
47. The EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is an effective inhibitor of tamoxifen-resistant breast cancer growth
48. Plant-derived and synthetic teratogens inhibit the ability of target tissues to respond to Sonic hedgehog signaling
49. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
50. Presence of fetal DNA in maternal plasma decades after pregnancy
51. A new class of homogeneous nucleic acid probes based on specific displacement hybridization
52. Identification and validation of p311 as a glioblastoma invasion gene using laser capture microdissection
53. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide